You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

117 Results
Guidelines and Advice
Feb 2016
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-24
Version: 3
Jan 2024
Drug
Other Name(s): Faslodex®
Jan 2024
Drug
Other Name(s): Megace® (multiple brands available)
Aug 2016
Drug
Other Name(s): Sandostatin® (multiple brands available) , Sandostatin® LAR™ (Novartis)
Aug 2016
Drug
Other Name(s): Zoladex® (AstraZeneca) , Zoladex® LA (AstraZeneca)
Mar 2016
Drug
Other Name(s): Lupron® (AbbVie) , Lupron Depot® (AbbVie) , Eligard® (Sanofi Aventis)
Aug 2016
Drug
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Drug
Other Name(s): Tagrisso®
Jan 2024
Regimen
Cancer Type:
Genitourinary, 
Testis
Intent: Curative
Apr 2016

Pages